✦ LIBER ✦

5.37 Myelodysplastic Syndrome and Acute Myeloid Leukemia Following Fludarabine plus Cyclophosphamide plus Rituximab in Patients with CLL

✍ Scribed by K. Maloum; C. Settegrana; J. Dupuis; A. Brion; J. Zini; B. Dreyfus; F. Cymbalista; F. Nguyen-Khac; V. Leblond

Book ID: 119218981
Publisher: Elsevier
Year: 2011
Tongue: English
Weight: 90 KB
Volume: 11
Category: Article
ISSN: 2152-2650
DOI: 10.1016/j.clml.2011.09.191

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intraoral Granulocytic Sarcoma in a Pati

Intraoral Granulocytic Sarcoma in a Patient With Myelodysplastic Syndrome Plus Acute Myeloid Leukemia

✍ CHAVES, FILIPE NOBRE; CARVALHO, FRANCISCO SAMUEL RODRIGUES; PATROCÍNIO, RÉGIA MA 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 55 KB

Therapy-related myelodysplastic syndrome

✍ M. Čolović; N. Suvajdžić; G. Janković; D. Tomin; N. Čolović; M. Denčić Fekete; V 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 154 KB

278: Treosulfan Plus Fludarabine for All

278: Treosulfan Plus Fludarabine for Allogeneic Hematopoietic Cell Transplantation (HCT) in Patients with Acute Leukemia and Myelodysplastic Syndrome

✍ E.R. Nemecek; B. Ly; T. Kovacsovics; R.T. Maziarz; J. Baumgart; J.E. Sanders; H. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Therapy-related myelodysplastic syndrome

✍ Gail J. Roboz; John M. Bennett; Morton Coleman; Ellen K. Ritchie; Richard R. Fur 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 100 KB

Treosulfan, Fludarabine, and 2-Gy Total

Treosulfan, Fludarabine, and 2-Gy Total Body Irradiation Followed by Allogeneic Hematopoietic Cell Transplantation in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia

✍ Gyurkocza, Boglarka; Gutman, Jonathan; Nemecek, Eneida R.; Bar, Merav; Milano, F 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 610 KB

Fractionated cyclophosphamide, vincristi

Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte-macrophage–colony stimulating factor (GM-CSF) alternating with methotrexate and cytarabine plus rituximab and GM-CSF in patients with Richter syndrome or fludarabine-refractory chronic lymphocytic leukemia

✍ Apostolia M. Tsimberidou; Hagop M. Kantarjian; Jorge Cortes; Deborah A. Thomas; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB

## Abstract ## BACKGROUND Therapy for patients with Richter syndrome (RS) or fludarabine‐refractory chronic lymphocytic leukemia (CLL) is unsatisfactory. A Phase II study was conducted to evaluate an alternating combination cytotoxic regimen given with rituximab and granulocyte‐macrophage–colony s